Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
Am J Hematol
; 97(3): E95-E99, 2022 03 01.
Article
in En
| MEDLINE
| ID: mdl-34904743
Full text:
1
Database:
MEDLINE
Main subject:
Piperidines
/
Adenine
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Tumor Suppressor Protein p53
/
Gene Deletion
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2022
Type:
Article